Medication info
Teliajm Sustained Release Tablet 10/500 mg

Teliajm Sustained Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Orange oval sustained release film-coated tablet
Packaging
For domestic use - 30 tablets per bottle
Approval status
Active

MFDS item code 202201432 · Approved 2022.04.04 · Insurance code 651205840

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It is especially helpful for those who are also following a diet and exercise regimen, effectively controlling blood sugar with the combined administration of teneligliptin and metformin. This helps maintain stable blood sugar levels, improving blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used to treat diabetes and helps manage blood sugar levels. However, it can very rarely cause a serious condition called lactic acidosis, so if symptoms of lactic acidosis appear, consult a doctor immediately. It should not be administered to patients with moderate to severe renal function impairment or in serious conditions such as heart failure, acute myocardial infarction, or sepsis. Additionally, before and after tests using radiographic contrast agents, the use of this medication should be temporarily suspended and renal function checked before resuming. It is advisable for women who are pregnant or may become pregnant, as well as patients with liver dysfunction, to avoid using this medication. Caution should be taken for potential hypoglycemia when used with insulin or sulfonylureas, and appropriate measures such as consuming sugar-containing foods should be taken if hypoglycemia symptoms appear. Care should be taken when administering to patients with a history of abdominal surgery or bowel obstruction, heart disease, or those at risk of QT interval prolongation. If symptoms of acute pancreatitis appear, immediate medical diagnosis is required, and medication may be halted. This medication includes the dye Yellow No. 5, so patients allergic to this ingredient should take caution. Regular checks on liver and kidney function should be performed during long-term use for any abnormal signs. Particularly in the elderly, careful dose adjustment and renal function checks are important due to the risk of reduced renal function. The risk of lactic acidosis increases when this medication is taken with alcohol, so it is advisable to avoid drinking. If breastfeeding, consult with a doctor regarding whether to continue breastfeeding as this medication can be secreted into breast milk. In case of overdose, visit a medical institution immediately for appropriate treatment, which may include blood dialysis if necessary. Patients and their families should be fully aware of and attentive to the symptoms of hypoglycemia and lactic acidosis while taking this medication. Furthermore, since there may be interactions with certain medications when taken concurrently, it is essential to inform the doctor or pharmacist about any other medications being taken. This medication is not used in children as its safety and efficacy have not been established.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, bowel obstruction, liver dysfunction, interstitial pneumonitis, bullous pemphigoid, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colon polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, elevated amylase, elevated lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, occult hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium concentration, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, shingles, limb pain, epigastric pain, gastritis, upper respiratory tract infection, tremors, headache, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory tract infection, rhinitis, cold sweat, diabetic retinopathy, vision loss, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, fatigue, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophil count, blood sugar abnormalities, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, intervertebral disc protrusion in the spine, intervertebral disc disorder in the spine, spinal ligament ossification, spinal foraminal stenosis, rotator cuff syndrome, bladder mass, ureteral calculi, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, biliary obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, dizziness, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, paresthesia, headache, muscle weakness, lower back pain, limb pain, lumbar spinal canal stenosis, tendonitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasms, foot deformities, hypertrophic osteoarthritis, bursitis, spinal osteoarthritis, intervertebral disc protrusion in the spine, intervertebral disc disorder in the spine, spinal ligament ossification, spinal foraminal stenosis, postmenopausal osteoporosis, rotator cuff syndrome, shingles, upper respiratory tract infection, gastroenteritis, pneumonia, H1N1 influenza, bronchitis, chronic sinusitis, folliculitis, cystitis, soft tissue infection, urinary tract infection, pharyngitis, streptococcal infection, tinea pedis, subcutaneous abscess, Helicobacter gastritis, vomiting, chronic gastritis, epigastric pain, stomatitis, esophagitis, gastrointestinal motility disorder, gastrointestinal motility decrease, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, increased blood sugar, abnormal sputum, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip damage, bruising, urticaria, glaucoma, blurry vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, dizziness, iron deficiency anemia, food allergy, pressure ulcer, hearing loss, endolymphatic hydrops, increased blood creatinine, increased blood urea, anemia, atrial fibrillation, hypothyroidism, dyspepsia, falls, animal bites, radial fracture, breast cancer, uterine abscess, ovarian cyst, vulvar pruritus, menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air entry and is best kept at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Orange oval sustained release film-coated tablet

Package unit

For domestic use - 30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.